Home»Entries posted by Rob Hill

AbbVie’s New Crohn’s Disease Drug Candidate

AbbVie’s drug Humira is currently the best-selling medication on the planet, and it is approved to treat a wide range of diseases, including Crohn’s Disease and ulcerative colitis. Recently, the company announced a partnership with a small biotech company called Galapagos to develop a JAK1 inhibitor for Crohn’s Disease. In the following video, health-care analyst […]

Weight Loss Physical Activity Improve GERD

ORLANDO, Fla. — Participants in a weight-loss program experienced improvement in GERD symptoms with successful weight loss in a study presented at Digestive Disease Week.In a prospective cohort study, researchers evaluated weight, calorie intake and responses to a validated reflux disease questionnaire (RDQ) in 213 obese and overweight participants enrolled in a structured weight-loss program. […]

Villous atrophy in Crohn’s disease linked to hip fracture

Villous atrophy in Crohn’s disease linked to hip fracture Healio Researchers evaluated 7,146 patients in Sweden with histologic evidence of Crohn’s disease (CD). All participants had undergone follow-up biopsy between 6 months and 5 years of CD diagnosis. The risk for fracture among patients who experienced … and more » Tags: Crohns, News and Events

AbbVie, Galapagos extend JAK1 pact into Crohn’s Disease

AbbVie ($ABBV) has made meds for inflammatory gastrointestinal ills a major theme of its deal-making activities this week. The North Chicago, IL-based drug giant and Belgium’s Galapagos ($GLPG) have agreed to expand their collaboration on an oral JAK1 inhibitor to include Crohn’s disease. Galapagos plans to fund and launch a midstage study of the compound, […]

Crohns Disease Diet and Nutrition

Crohns Disease Diet and Nutrition, PHOENIX More than a million people in the United States suffer from inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. And while we don’t know what causes them, we do know that genetic and environmental components are at the root of these autoimmune diseases. Crohn’s disease can affect the […]

Patient Centered Decision Making Improved Health Outcomes

Formulating care plans on the basis of patient-specific circumstances and needs was associated with improved health care outcomes, according to data reported in Annals of Internal Medicine, from a study funded by the Department of Veterans Affairs.“In previous research, we have found that physicians do a pretty good job of following algorithmic treatment guidelines, but […]

Adalimumab Effective for Crohn’s Disease

Adalimumab Effective for Crohn’s Disease n a double blind, multicenter trial in the Netherlands, researchers evaluated 76 adults with Crohn’s disease (CD) and perianal fistulizing disease treated with adalimumab once every 2 weeks along with either placebo (n=39) or 500 mg ciprofloxacin (CIP, n=37) twice daily for 12 weeks. Adalimumab was continued until completion of […]

1 2 3 32

No Guts Know Glory



IBD Adventures